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Abstract
SARS-coronavirus (SARS-CoV) replication and transcription are mediated by a replication/transcription complex (RTC) of
which virus-encoded, non-structural proteins (nsps) are the primary constituents. The 16 SARS-CoV nsps are produced by
autoprocessing of two large precursor polyproteins. The RTC is believed to be associated with characteristic virus-induced
double-membrane structures in the cytoplasm of SARS-CoV-infected cells. To investigate the link between these structures
and viral RNA synthesis, and to dissect RTC organization and function, we isolated active RTCs from infected cells and used
them to develop the first robust assay for their in vitro activity. The synthesis of genomic RNA and all eight subgenomic
mRNAs was faithfully reproduced by the RTC in this in vitro system. Mainly positive-strand RNAs were synthesized and
protein synthesis was not required for RTC activity in vitro. All RTC activity, enzymatic and putative membrane-spanning
nsps, and viral RNA cosedimented with heavy membrane structures. Furthermore, the pelleted RTC required the addition of
a cytoplasmic host factor for reconstitution of its in vitro activity. Newly synthesized subgenomic RNA appeared to be
released, while genomic RNA remained predominantly associated with the RTC-containing fraction. RTC activity was
destroyed by detergent treatment, suggesting an important role for membranes. The RTC appeared to be protected by
membranes, as newly synthesized viral RNA and several replicase/transcriptase subunits were protease- and nuclease-
resistant and became susceptible to degradation only upon addition of a non-ionic detergent. Our data establish a vital
functional dependence of SARS-CoV RNA synthesis on virus-induced membrane structures.
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Introduction
Following infection and genome translation, positive-strand
RNA (+RNA) viruses establish a cytoplasmic enzyme complex that
directs the amplification and expression of their genome. The viral
RNA-dependent RNA polymerase (RdRp) is the central enzyme
of this ‘replication/transcription complex’ (RTC), but it also may
include other viral non-structural proteins (nsps) and host factors
that cooperate to synthesize viral RNA. Over the past decade, it
has become clear that +RNA virus RTCs are invariably associated
with virus-induced membrane structures, which are poorly
characterized but presumably provide a framework for RNA
synthesis by facilitating the concentration and cooperation of viral
macromolecules on a dedicated membrane surface. They may also
protect the viral RNA from nucleases in the cytoplasm of the host
cell, aid in shielding the double-stranded RNA intermediates of
virus replication from the host cell’s innate immune system, or
contribute to the coordination of the viral life cycle in time and
space. These membrane-bound RTCs are the molecular machines
that drive the RNA synthesis and evolution of +RNA viruses.
Clearly, unraveling their structure and function will be critical to
understand the biochemistry of +RNA virus replication and
develop novel antiviral control strategies.
The RTC of coronaviruses, including that of SARS-coronavirus
(SARS-CoV), the causative agent of the life-threatening severe
acute respiratory syndrome (for a review, see reference [1]), stands
out for a number of reasons. First, at 27–32 kb, the polycistronic
coronavirus genome is by far the largest genome among currently
known RNA viruses [2]. Second, the viral RNA-synthesizing
machinery not only amplifies the genome, but also directs the
synthesis of a set of subgenomic (sg) mRNAs (eight in the case of
SARS-CoV; RNA2 to RNA9) to express the viral accessory and
structural protein genes. The latter are produced from a
corresponding set of subgenome-length negative strand RNAs,
which derive from discontinuous negative-strand RNA synthesis
[3,4]. Third, the viral replicase/transcriptase (which will be
referred to as ‘‘replicase’’ for brevity) is of unprecedented size
and complexity [5,6]. It is produced by translation of the partly
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expression of the latter requiring a -1 ribosomal frameshift near
the end of ORF1a. In this manner, SARS-CoV genome
translation yields the large replicase polyproteins pp1a (4,382 aa)
and pp1ab (7,073 aa). Extensive autoproteolytic processing,
mediated by two ORF1a-encoded protease domains [7–10],
ultimately generates 16 nsps [5,6,11,12]. These include key
replicative enzymes (e.g. the nsp12-RdRp [13], and the nsp13-
helicase [14]), a variety of subunits containing presumed accessory
functions for viral RNA synthesis (e.g. the nsp8-primase [15,16],
nsp14-exoribonuclease [17,18], and nsp15-endoribonuclease Nen-
doU [19–22]) and several predicted multi-spanning membrane
proteins (nsp3, nsp4 and nsp6; [23,24]) that presumably modify
cellular endomembranes and target the RTC to this scaffold.
Immunofluorescence microscopy previously revealed that newly
synthesized SARS-CoV RNA and several nsps colocalize in
perinuclear foci in SARS-CoV-infected cells [8,14,25–27]. Elec-
tron microscopy established the presence of typical paired
membranes, membrane whorls, and double-membrane vesicles
(DMVs), which labeled for nsps [26–29] and viral RNA [27] and
were therefore proposed to carry the SARS-CoV RTC. The
endoplasmic reticulum (ER) was identified as the most likely
membrane donor [26] and recent electron tomography studies
indeed revealed a network of SARS-CoV-induced membrane
structures that is continuous with this organelle (Knoops et al., in
preparation). In the past four years, substantial progress has been
made in the characterization of individual replicase subunits using
enzymatic assays, reverse and classical genetics, bioinformatics and
structural studies. However, the composition and mechanistics of
the native ribonucleoprotein complexes, in which these different
components interact to drive coronavirus replication and tran-
scription, have remained completely uncharacterized thus far. We
therefore set out to isolate active RTCs from SARS-CoV-infected
cells and used those to develop an in vitro system that faithfully
reproduced the synthesis of both genomic and sg RNAs, mainly of
positive polarity. RTC activity cosedimented with newly synthe-
sized viral RNA and several replicase subunits in a dense
membrane fraction containing structures that could be labeled
for nsp3 and nsp4. The in vitro activity of the pelleted RTC
depended on the presence of a cytoplasmic host factor.
Furthermore, RTC activity was destroyed by addition of (non-
ionic) detergents, which also released replicase subunits and
(mainly) sg RNA from the membrane fraction. Protease and
nuclease protection experiments indicated that viral RNA and
nsps were protected by membranes, thus further substantiating the
functional connection between SARS-CoV RNA synthesis and
virus-induced membrane structures that appear to be essential for
RTC activity.
Results
Isolation of active SARS-CoV RTCs
In order to characterize isolated SARS-CoV RTCs, we
developed an in vitro RNA synthesis assay (IVRA) to study their
activity in vitro. In this reaction, the incorporation of [a-
32P]CTP
into viral RNA was analyzed in a mixture containing NTPs, Mg
2+,
an ATP-regenerating system, and an inhibitor of cellular
transcription (Actinomycin D). The RTC activity in cytoplasmic
extracts prepared from SARS-CoV-infected Vero-E6 cells pro-
duced a set of
32P-labeled RNA molecules with sizes correspond-
ing to those of the SARS-CoV genome and all eight sg RNAs
(Fig. 1). These products were not detected when using mock-
infected cell lysates (Fig. 1A, mock), demonstrating that SARS-
CoV RTC activity was responsible for their synthesis. Reaction
conditions were optimized by varying several parameters,
including the composition of the reaction mixture, incubation
time, temperature, and the Mg
2+ concentration (Fig. 1 and data
not shown). In a time course experiment, in vitro synthesized viral
RNA accumulated up to 100 min into the reaction (Fig. 1A), after
which a decrease was observed, probably due to declining RTC
activity in combination with continued RNA degradation by
cellular nucleases. The optimal reaction temperature was 30uC
(Fig. 1B). RTC activity was strongly dependent on the Mg
2+
concentration and was maximal when 2 mM of Mg
2+ was added
to the reaction (Fig. 1C). Manganese could not replace Mg
2+,a s
IVRAs containing Mn
2+ only yielded a ladder of small
radiolabeled RNA molecules with aberrant sizes (Fig. 1D),
suggesting an effect on RdRp processivity. Addition of ionic
(SDS and deoxycholate (DOC)) or non-ionic detergents (Nonidet
P40 (NP-40) and Triton X-100 (TX-100)) to the post-nuclear
supernatant (PNS) prior to the IVRA completely abolished the
accumulation of radiolabeled viral RNA, suggesting that the
integrity of membranes is an important factor for SARS-CoV
RTC activity (Fig. 1D).
To determine the polarity of the in vitro produced RNAs, the
32P-labeled products of an IVRA were hybridized to a membrane
containing immobilized RNA probes specific for SARS-CoV
positive- or negative-stranded RNA (Fig. 1E). A strong hybridiza-
tion with the positive strand-specific probe was observed,
demonstrating that the RTC mainly synthesized RNA of positive
polarity in vitro. After longer exposure times, a small quantity of
radiolabeled material hybridizing to the negative strand-specific
probe became visible, but a similar signal was observed with the
negative control RNA (Fig. 1E). This indicated that the quantity of
in vitro synthesized negative-stranded RNA was very small (less
than 2% of the total RNA), which is in line with the large excess of
positive over negative strands that is commonly observed in vivo.
Protein synthesis is not required for RTC activity in vitro
To assess whether protein synthesis occurred during IVRAs, we
determined whether
35S-labeled amino acids were incorporated
Author Summary
The SARS-coronavirus (SARS-CoV), which causes the life-
threatening severe acute respiratory syndrome, replicates
in the cytoplasm of infected host cells. A critical early step
in the SARS-CoV life cycle is the formation of a replication/
transcription complex (RTC) that drives viral genome
replication and subgenomic mRNA synthesis. Virus-encod-
ed enzymes form the core of this RTC, which is believed to
be associated with characteristic virus-induced membrane
structures derived from modified host cell membranes. To
investigate the connection between these membrane
structures and SARS-CoV RNA synthesis, and to character-
ize RTC composition and function, we isolated these
complexes and developed the first in vitro assay to study
their activity. SARS-CoV genomic RNA and all eight
subgenomic mRNAs were synthesized in this in vitro
reaction. By centrifugation, RTC activity could be isolated
from the cytoplasm, together with membrane structures,
viral enzymes, and RNA. The activity of these isolated RTCs
was dependent on a cytoplasmic host factor. RTC activity
was destroyed by detergent treatment, suggesting a
critical role for membranes that appeared to protect the
complex against protease and nuclease digestion. Our
data establish a functional connection between viral RNA
synthesis and intracellular membranes and show that host
factors play a crucial role in SARS-CoV RNA synthesis.
SARS-Coronavirus RNA Synthesis and Membranes
PLoS Pathogens | www.plospathogens.org 2 May 2008 | Volume 4 | Issue 5 | e1000054into proteins during a 100-min reaction. When using the PNS of
uninfected cells, SDS-PAGE revealed a smear of
35S-labeled
material (Fig. 2A, lane 2). These products were absent when the
PNS was heated to 96uC for 5 min prior to the assay (Fig. 2A, lane
1), suggesting they resulted from translation under IVRA
conditions. When using the PNS of SARS-CoV-infected cells,
we observed incorporation of radiolabel also into a set of discrete
polypeptides (Fig. 2A, lane 4), including species with sizes
matching those of the SARS-CoV membrane (M) and nucleocap-
sid (N) proteins. This was likely due to the fact that the lysate
contained large amounts of the sg mRNAs encoding these
proteins, possibly in combination with the virus-induced shut-off
of host cell translation [30]. Protein synthesis was completely
inhibited when the translation inhibitors cycloheximide or
puromycin were present during the IVRA (Fig. 2A, lanes 5 and
6), but this did not affect in vitro RTC activity since the quantity of
radiolabeled RNA products was unchanged (Fig. 2B).
The activity of isolated RTCs depends on a cytoplasmic
host factor
To further characterize the active RTC, the PNS of SARS-
CoV-infected cells was subjected to differential centrifugation. A
Figure 1. In vitro RNA synthesizing activity of SARS-CoV RTCs. Incorporation of [a-
32P]CTP into viral RNA in IVRAs with PNS from SARS-CoV- or
mock-infected cells was analyzed by denaturing formaldehyde-agarose gel electrophoresis, followed by PhosphorImager analysis. To optimize
reaction conditions, the reaction time (A), temperature (B) and Mg
2+ concentration (C) were varied, as indicated above the lanes. Except for the
parameter that was varied, standardized conditions were used, as described in ‘‘Materials and Methods’’. The ‘‘mock’’ lane contains the reaction
products from a standard 100-min IVRA performed with a PNS from mock-infected cells. (D) IVRAs with 2 mM Mn
2+ instead of Mg
2+ or with 0.1% SDS,
0.03% DOC, 0.01% NP-40, or 0.01% TX-100 added, as indicated above the lanes. The position of RNAs 1-9 are indicated and were determined by
including a lane (hyb) with RNA isolated from SARS-CoV-infected cells that was hybridized with a probe complementary to the 39 end of all viral RNAs.
The seemingly different ratios between genomic and sgRNA, when IVRA results are compared with the hybridization data, are explained by the fact
that the former reflect the (size-dependent) incorporation of label whereas the latter show molar abundance. The molar ratios of IVRA products,
calculated using the C-content of each RNA species, are similar to those in infected cells. (E) Analysis of the polarity of in vitro synthesized SARS-CoV
RNA. A membrane containing immobilized SARS-CoV RNA probes of positive (39-TR(+)) or negative polarity (39-TR(-)) was hybridized with the
32P-
labeled RNA products of an IVRA. RNA probes derived from the equine arteritis virus genome (ctrl. a) or its complement (ctrl. b) were included as
negative controls. See Materials and Methods for probe details. A short and a long exposure of the same hybridization are shown.
doi:10.1371/journal.ppat.1000054.g001
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(Fig. 3, lane 2), but only a trace amount of the original activity was
recovered in the 10,0006g pellet fraction P10 (Fig. 3, lane 4).
Surprisingly, RTC activity in this P10 fraction could be largely
restored by adding an aliquot of the cytoplasmic S10 fraction
(Fig. 3, lane 5). An S10 fraction prepared from mock-infected cells
was equally capable of restoring the RTC activity in P10,
indicating that a cytoplasmic host factor was required (Fig. 3,
lane 6). Routinely, about 50% of the RTC activity that was
originally present in the PNS could be recovered in the P10
fraction (in assays supplemented with S10). Remarkably, virtually
all replicative activity was lost, while transcription was only 2- to 3-
fold decreased, in the P10 fraction depleted of the host factor
(Fig. 3, lane 4). The sedimentation of the RTC activity at
10,0006g suggests that it is associated with heavy membrane
structures.
RTC activity cosediments with membrane structures
The P10 fraction, which contained the bulk of RTC activity,
was analyzed by electron microscopy (negative staining) in
combination with an immunogold labeling for the (putative)
transmembrane proteins nsp3, nsp4, and nsp6 (Fig. 4 and data not
shown). Clusters of vesicles (with diameters between 100 and
350 nm) were observed, which appeared to be associated with
more tubular or flattened membrane structures. A strong
immunolabeling of these structures for SARS-CoV nsp3 (Fig. 4A)
and nsp4 (Fig. 4B) was observed. Membrane structures immuno-
Figure 2. Protein synthesis is not required for RTC activity in vitro. (A) Incorporation of
35S-labeled amino acids into proteins during a 100-
min IVRA. Proteins were separated by SDS-PAGE and incorporation of radiolabel was visualized by phosphorimaging of the dried gel. PNS from either
uninfected or SARS-CoV-infected cells was used, which was either untreated (2) or heated to 96uC prior to the reaction, as indicated above the lanes.
Reactions were performed in the absence (2) or presence of the translation inhibitors cycloheximide (+CHX) or puromycin (+PUR). The positions of
protein size markers are indicated on the left and the arrows on the right indicate the positions of polypeptides with sizes matching those of SARS-
CoV membrane (M) and nucleocapsid (N) proteins. (B) The effect of translation inhibitors on in vitro RTC activity. IVRAs were performed in the absence
(2) or presence of cycloheximide (+CHX) or puromycin (+PUR) as indicated above the lanes. Reaction products were analyzed as described in the
legend to Fig. 1.
doi:10.1371/journal.ppat.1000054.g002
Figure 3. The activity of isolated RTCs is dependent on a
cytoplasmic host factor. The PNS of SARS-CoV-infected or uninfect-
ed cells was subjected to differential centrifugation after which IVRAs
were performed using the PNS (lane 1), 10,0006g pellet (P10), and
supernatant (S10) fractions, either on a single fraction or combinations
of them, as indicated above the lanes. Reaction products were analyzed
as described in the legend to Fig. 1.
doi:10.1371/journal.ppat.1000054.g003
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detected in a control P10 fraction prepared from mock-infected
cells. Occasionally, double membranes could be distinguished
(Fig. 4B, arrow). These observations are consistent with the notion
that the P10 fraction is enriched for SARS-CoV-induced nsp-
containing membrane structures that have been documented in
infected cells.
Product-specific differences in the release of SARS-CoV
RNAs from the RTC
The distribution of newly synthesized SARS-CoV RNAs
between the RTC-containing P10 and cytoplasmic S10 fractions
was analyzed by fractionation of PNS after an IVRA (Fig. 5A).
The bulk (76%) of newly made genomic RNA was recovered from
the P10 fraction, suggesting it remained associated with the heavy
membrane structures. In contrast, newly synthesized sg RNAs
were, depending on their size, progressively more abundant in
S10, suggesting their release from the RTC. To further investigate
the role of membranes in RNA localization, an IVRA was
performed with PNS, after which 0.5% TX-100 was added and
the distribution of viral RNAs between P10 and S10 was analyzed
(Fig. 5B). The bulk of the smaller RNA species (RNA5-9) was now
recovered from the S10 fraction. In contrast, one-half of the
genomic RNA remained associated with the P10 fraction after
detergent treatment, suggesting product-specific differences in
RTC operation and organization, which appears to include partly
detergent-resistant structures.
Replicase subunits co-sedimenting with the membrane-
associated RTC
For selected nsps, for which suitable antisera that are reactive in
Western blot experiments were available, the distribution between
the cytoplasmic S10 fraction and the RTC-containing P10 fraction
was analyzed. This revealed that these RTC subunits were
enriched or mainly present in the P10 fraction (Fig. 6). The bulk of
nsp3 was in the P10 fraction and nsp5 was found almost
exclusively in the P10 fraction (Fig. 6, lane 3). Most of nsp8 was
detected in the P10 fraction although also a substantial amount
was found in the cytoplasmic fraction (Fig. 6, lane 2 & 3).
Treatment of PNS with 0.5% TX-100 prior to P10-S10
fractionation, led to the redistribution of nsp3, nsp5, and nsp8,
which were no longer found in the P10 fraction, but were
recovered at increased levels in the S10 fraction (Fig. 6, lanes 4 &
5). This suggests that their direct or indirect association with
membranes caused them to cosediment with the RTC activity in
the P10 fraction.
SARS-CoV nascent RNA and replicase subunits reside in a
membrane-protected RTC
To further assess the role of membranes in SARS-CoV RNA
synthesis, it was investigated whether they protect the RTC. A
standard 100-min IVRA was performed, followed by treatment
with the nuclease Bal31, a non-specific nuclease that degrades
both single- and double-stranded RNA, in the presence or absence
of 0.5% TX-100. After fractionation of the samples into P10 and
S10, the quantity of in vitro synthesized radiolabeled RNA in each
fraction was analyzed (Fig. 7A). In untreated control samples,
newly made viral RNA was found both associated with the RTC
in the P10 fraction (predominantly genomic RNA) as well as
released in the cytoplasmic S10 fraction (enriched in sg RNA;
Figure 4. Electron micrographs of the P10 fractions of SARS-CoV-infected cells. Immunogold labeling of the P10 fraction of SARS-CoV-
infected (A, B) or uninfected (C) Vero-E6 cells using rabbit antisera recognizing nsp3 (A, C) or nsp4 (B) was followed by negative staining. The white
arrow indicates a part of the specimen clearly showing double membranes. Scale bar: 500 nm.
doi:10.1371/journal.ppat.1000054.g004
Figure 5. Distribution of newly synthesized SARS-CoV RNA
between the RTC-containing P10 and the cytoplasmic S10
fraction. After an IVRA with the PNS from SARS-CoV infected cells,
0.5% TX-100 (B) or no detergent (A) was added and the samples were
fractionated into S10 and P10 fractions. Equivalent amounts of S10 and
P10 (indicated with S and P above the lanes) derived from the same
number of cells were analyzed. The levels of the five most abundant
RNAs in P10 and S10 fractions were quantified and for each RNA
molecule the percentage that is present in P10 is indicated to the right
of the gel. The signals for RNA4 and RNA6-8 were too low to be
quantified reliably.
doi:10.1371/journal.ppat.1000054.g005
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was completely degraded upon nuclease treatment (Fig 7A, lane 3),
while the RNA associated with the RTC was protected (Fig 7A,
lane 4). The latter products only became susceptible to nuclease
treatment upon addition of 0.5% TX-100, suggesting that the
replicating RNA is enclosed by membranes (Fig 7A, compare lanes
4 and 6).
To determine whether also replicase subunits were protected by
membranes, PNS was treated with proteinase K, either in the
absence or presence of 0.5% TX-100. Protease-treated samples
and untreated controls were subsequently fractionated into P10
and S10, after which the presence of nsp3, nsp5, and nsp8 was
probed by Western blotting (Fig. 7B). Both cytoplasmic nsp3 in
S10 and pelleted nsp3 in P10 were susceptible to protease
treatment (Fig. 7B, top panel). The nsp5 subunit, which mainly
cosedimented with the RTC in P10, was largely resistant to
protease treatment (Fig 7B, middle panel, lane 5), but it was
degraded in the presence of TX-100. The observed protease-
resistance of nsp5 is not due to a lack of proteinase K activity, since
both nsp3 and a host protein cross-reacting with the nsp5
antiserum were completely degraded in this same sample.
Likewise, nsp8 in the P10 fraction was resistant to protease
treatment, and, surprisingly, this was also true for the nsp8 that
was present in the S10 fraction (Fig. 7B, lower panel). Both forms
of nsp8 were susceptible to the protease in the presence of a non-
ionic detergent (TX-100). These data suggest that nsp5 and nsp8
were enclosed by membranes. In agreement with the membrane
topology predictions for the nsp3 domains used to raise our
antiserum [5,23], a major part of nsp3 was exposed on the surface
of these membrane structures.
Discussion
The SARS-CoV RTC, like the RTCs of other +RNA viruses
[31–33], is believed to be associated with virus-induced structures
derived from intracellular membranes. The coronavirus RTC is
composed of an unusually large number of subunits, including
several nsps with unique enzyme functions [2,34]. Despite steady
progress, the functional characterization of the 16 SARS-CoV
nsps, including the RdRp and helicase enzymes that are central to
replication, is still in an early stage. To investigate the details of the
molecular interplay between these subunits, the viral RNA
template, and host factors, in vitro assays for viral RNA synthesis
will be indispensable. By now, the soluble expression and
purification of several individual coronavirus nsps has proven to
Figure 6. Distribution of SARS-CoV nsps between the cyto-
plasmic S10 fraction and RTC-containing P10 fraction. PNS from
SARS-CoV-infected cells was either untreated (lanes 2 & 3) or treated
with 0.5% TX-100 (lanes 4 & 5) after which it was fractionated into a
10,0006g supernatant (S) and pellet (P). Equivalent amounts of S10 and
P10 derived from the same number of cells were analyzed by Western
blotting with antisera recognizing nsp3, nsp5, and nsp8 antisera. Lane 1
contains the PNS from mock-infected cells. The position of a cross-
reacting host protein that was recognized by the nsp5 antiserum is
indicated by ‘‘host pr.’’ to the left of the center panel.
doi:10.1371/journal.ppat.1000054.g006
Figure 7. Protection of newly synthesized SARS-CoV RNA and nsps by membranes. (A) After a standard 100-min IVRA, PNS was either
directly fractionated into a 10,000g pellet (lane2) and supernatant (lane 1) or treated, prior to fractionation, with nuclease Bal31 (lanes 3-6) in the
presence (lanes 5 & 6) and absence (lanes 3 & 4) of 0.5% TX-100. The presence of in vitro synthesized radiolabeled viral RNA in the fractions was
analyzed as described in the legend of Fig. 5. (B) PNS was directly fractionated into a 10,000g pellet (lane3) and supernatant (lane 2) or treated with
proteinase K (lanes 4–7) in the presence (lanes 6 & 7) and absence (lanes 4 & 5) of 0.5% TX-100 prior to fractionation. The presence of nsp3, nsp5 and
nsp8 in these fractions was analyzed by Western blotting, as described in the legend of Fig. 6. Lane 1 contains the PNS from mock-infected cells. The
position of a host protein cross-reacting with the nsp5 antiserum is indicated by ‘‘host pr.’’ to the left of the blot.
doi:10.1371/journal.ppat.1000054.g007
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nature of the complex, this suggests that the reconstitution of the
RTC from its purified components, remains a distant perspective.
As a complementary approach, we therefore set out to isolate the
active SARS-CoV RTC from the only currently available source:
virus-infected cells. The newly developed IVRA described in this
paper (Fig. 1) will allow us to obtain more insight into the
architecture and function of the SARS-CoV RTC as a whole,
and may aid to address the poorly defined role of cellular
membranes.
Although RdRp activity in cell lysates was previously reported
for the coronaviruses mouse hepatitis virus and transmissible
gastroenteritis virus [35–40], this is to our knowledge the first
description of a robust in vitro system for coronavirus RNA
synthesis that produces the full spectrum of viral mRNAs (both
genomic and sg RNAs) generated in infected cells. A similar in vitro
system was recently developed for the distantly related arterivirus
equine arteritis virus (manuscript in preparation), suggesting that
our method may be generally applicable to nidovirus RTCs.
Protein synthesis occurred in our lysates under the IVRA
conditions used, but its inhibition did not affect in vitro RTC
activity (Fig. 2). This suggests that, in contrast to what was
described for cells infected with mouse hepatitis virus [41–43] or
SARS-CoV (our unpublished data), continued translation is not
required for RTC activity in vitro. Likely, inhibition of protein
synthesis does not influence the activity of the preformed, active
RTCs present in our PNS, which are mainly synthesizing RNA of
positive polarity (Fig. 1E).
Currently, suitable small SARS-CoV RNA replicons, which
could be added to an IVRA as exogenous template and be
distinguished from natural viral RNAs on the basis of size, are not
available. Consequently, addressing the question whether de novo
initiation of RNA synthesis occurs in our system must wait until
further technical advances (in this area) have been made. Still, a
potential complication may be the inability of such exogenous
templates to enter the membrane-protected RTC, as also observed
in this study for molecules like Bal31 nuclease and proteinase K
(Fig. 7).
SARS-CoV RTC activity was recovered in a 10,0006g heavy
membrane pellet (P10), but the isolated RTCs had to be
supplemented with an S10 fraction from infected or uninfected
cells to regain activity (Fig. 3). This indicates that, besides the host
factors possibly associated with the RTC in the P10 fraction, also a
cytoplasmic host factor is required for SARS-CoV RNA synthesis.
The nature of this host factor is currently being analyzed.
Replication appeared to be particularly dependent on the presence
of this host factor. While transcription was only 2- to 3-fold
reduced, replication was barely detectable in the P10 fraction
depleted of the host factor (Fig. 3). Whether this difference is
merely due to the larger size of the genomic RNA and/or reflects a
higher demand or specific role for the host factor in replication
remains to be investigated in more detail. The RTC activity
cosedimented with newly synthesized viral RNA, several replicase
subunits and nsp3-, nsp4- and nsp6-containing membrane
structures. The latter proteins are (putative) multi-spanning
transmembrane proteins [23,24,44] presumed to be important in
the induction of the RTC-related membrane rearrangements that
accompany SARS-CoV infection [26,27]. Furthermore, the
cosedimentation of nsp3 with the RTC (Fig. 6) may indicate that
one or multiple of the enzymatic activities of this multidomain
protein [5] are important for RNA synthesis. All of the nsp5 main
proteinase copurified with RTC activity in the P10 fraction,
although it remains to be investigated whether this finding is
directly related to the site of replicase polyprotein processing. The
RTC’s core enzyme, the nsp12-RdRp, has been postulated to
work in concert with a unique second RdRp activity that was
recently identified in nsp8. Its proposed RNA primase activity
[15,45] would be consistent with the (partial) cosedimentation of
nsp8 with the RTC that we observed in this study (Fig. 6). After
TX-100 treatment, nsp3, nsp5, and nsp8 no longer cosedimented
in P10, suggesting they had been released from the membrane
structures. In addition, protease protection experiments in the
absence and presence of detergents revealed that nsp5 and (part of)
nsp8 were shielded by membranes, while the predicted cytoplas-
mic domains of nsp3 were not [23]. The experiments in Fig. 7
indicated that a cytoplasmic form of nsp8 (in S10) was also
shielded from protease activity by membranes. This suggests the
existence of membrane structures distinct from the RTC-
containing complexes in P10. The cosedimentation of nsp3,
nsp5, and nsp8 with RTC activity is in line with their
colocalization in specific structures in the perinuclear region of
SARS-CoV-infected cells, as observed by immunofluorescence
microscopy [25,26].
Free RNA of transmissible gastroenteritis virus was previously
found to be susceptible to nuclease treatment, whereas most
negative-stranded RNAs, and a small fraction of (probably
nascent) positive-stranded RNAs, were present in membrane-
protected complexes [46]. In our study, non-ionic detergents
rendered SARS-CoV RNA susceptible to nuclease digestion
(Fig. 7) and destroyed all RTC activity (Fig. 1). This again signifies
the importance of intact membrane structures for viral RNA
synthesis. Their disruption may have dissociated the active enzyme
complex and/or changed the RTC’s microenvironment, or may
have provided access to cytoplasmic nucleases.
The bulk of newly synthesized SARS-CoV genome remained
associated with the RTC-containing heavy membrane structures,
while sg RNAs appeared to be more readily released from the
structures in which they had been synthesized. In previous studies
with transmissible gastroenteritis virus, it was also found that
preferentially sg RNAs were no longer associated with the
membrane-associated complexes [46]. The released RNA mole-
cules might represent a pool of mRNAs destined for translation
into structural and accessory proteins (sg RNAs) and additional
replicase proteins (RNA1), while the RTC-associated RNAs might
be engaged in replication and/or packaging. In this manner, the
intracellular compartmentalization mediated by the formation of
specialized membrane structures might also serve to coordinate
different steps in the viral life cycle and/or enhance their
specificity for viral RNA. Surprisingly, after treatment with 0.5%
TX-100, a large fraction of genomic RNA remained in the
10,0006g pellet, suggesting it is associated with detergent-resistant
structures. This might indicate that, as postulated for hepatitis C
virus replication complexes [47–49], the SARS-CoV RTC is
associated with lipid rafts or lipid droplets, a feature that could also
explain the proposed role of lipid rafts during the early stages of
SARS-CoV replication [50].
If SARS-CoV RTCs, as this study suggests, are enclosed by
membranes that may provide an optimal environment for viral
RNA synthesis, this raises the question of how newly synthesized
RNA products are released from these structures. Moreover, the
fact that RTC activity depends on a cytoplasmic host factor that
does not cosediment with the complex is an additional indication
that crosstalk between cytoplasm and RTC-containing membrane
structures must occur, e.g. via channels that may facilitate
transport across membranes. Taken together, our data support
the existence of a functional link between SARS-CoV RNA
synthesis and the unusual membrane structures induced upon
coronavirus infection.
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Cells, virus and antisera
Vero-E6 cells were infected with SARS-CoV (strain Frankfurt 1)
at a multiplicity of infection of 5 as described previously [26]. All
procedures involving live SARS-CoV were performed in the
biosafety level 3 facility at Leiden University Medical Center.
Rabbit antisera recognizing nsp3, nsp5, and nsp8 were described
previously [26]. Antisera against nsp4 and nsp6 were raised in
New Zealand White rabbits using as antigens the bovine serum
albumin-coupled synthetic peptides FSNSGADVLYQPPQTSIT-
SAVLQ and LNIKLLGIGGKPCIKVATVQ, representing the
C-terminal sequences of nsp4 and nsp6, respectively.
Isolation of enzymatically active RTCs by subcellular
fractionation of SARS-CoV-infected cells
SARS-CoV- or mock-infected cells (eight 175 cm
2 flasks) were
harvested by trypsinization at 10 hours post infection. To inhibit
cellular transcription, 2 mg/ml actinomycin D was present in all
solutions used for harvesting and washing of the cells. After
washing with PBS, cells were resuspended in 2 ml ice-cold
hypotonic buffer (20 mM HEPES, 10 mM KCl, 1.5 mM
MgOAc2, 1 mM DTT, 133 U/ml RNaseOUT (Invitrogen) and
2 mg/ml actinomycin D, pH 7.4) and incubated for 10 min at
4uC. Cells were disrupted using a Dounce homogenizer by giving
30 strokes with a tight fitting pestle. Isotonic conditions were
restored by adding HEPES, sucrose, and DTT, which resulted in a
final lysate containing 35 mM HEPES, pH 7.4, 250 mM sucrose,
8 mM KCl, 2.5 mM DTT, 1 mM MgOAc2,2mg/ml actinomy-
cin D, and 130 U/ml RNaseOUT. Nuclei, large debris, and any
remaining intact cells were removed by two successive 5-min
centrifugations at 1,0006g, and the resulting PNS was either
assayed immediately for RTC activity or stored at 280uC. The
SARS-CoV titer present in PNS was approximately 10
8 plaque-
forming units per ml. Plaque assays performed before and after
IVRAs revealed that no measurable de novo virus production
occurred during this assay (data not shown). A 10,0006g pellet
(P10) and supernatant (S10) fraction were prepared from PNS by
centrifugation at 10,0006g for 10 min. The pellet was resus-
pended in dilution buffer (35 mM HEPES, 250 mM sucrose,
8 mM KCl, 2.5 mM DTT, 1 mM MgOAc2, pH 7.4), in 1/10 of
the original PNS volume from which the pellet had been prepared.
In some experiments, PNS was incubated for 15 min at 4uC with
0.5% TX-100 prior to the preparation of P10 and S10 fractions.
In vitro RNA synthesis assay (IVRA)
Assays were performed using either 25 ml PNS, 20 ml S10, 5 ml
P10, or 5 ml P10 supplemented with 20 ml S10. When required,
the total volume was adjusted to 25 ml with dilution buffer. The
subsequent addition of reaction components yielded a 28 ml final
reaction volume, containing 30 mM HEPES pH 7.4, 220 mM
sucrose, 7 mM KCl, 2.5 mM DTT, 2 mM MgOAc2,2mg/ml
actinomycin D, 25 U RNaseOUT, 20 mM creatine phosphate
(Sigma), 10 U/ml creatine phosphokinase (Sigma), 1 mM ATP,
0.25 mM GTP, 0.25 mM UTP, 0.6 mM CTP and 0.12 mM and
10 mCi [a-
32P]CTP (GE Healthcare). Unless otherwise indicated,
IVRAs were performed for 100 min at 30uC. Reactions were
terminated by adding 60 ml of a mixture containing 5% lithium
dodecyl sulfate, 0.1 M Tris-HCl, pH 8.0, 0.5 M LiCl, 10 mM
EDTA, 5 mM DTT, and 0.1 mg/ml proteinase K, and
incubating at 37uC for 10 min. When protein synthesis was
tested, [a-
32P]CTP was replaced with 14.3 mCi of Promix (GE
Healthcare), containing a mixture of [
35S]methionine and
[
35S]cysteine. To assess the effect of translation inhibition,
70 mg/ml of cycloheximide or 350 mg/ml of puromycin were
added.
RNA Isolation and analysis
RNA was isolated from IVRA reaction mixtures by acid phenol
extraction and isopropanol precipitation. Reaction products were
analyzed by denaturing formaldehyde agarose gel electrophoresis
essentially as described previously, except that a 1% agarose gel
was used [51]. Radiolabeled in vitro synthesized RNA was detected
by exposing a PhosphorImager screen directly to the dried gel,
after which screens were scanned with a Personal Molecular
Imager FX (Bio-Rad) and data were analyzed with Quantity One
version 4.5.1 (Bio-Rad). Unlabeled endogenous SARS-CoV RNA
was detected by hybridization with a
32P-labeled oligonucleotide
SARSV002 (59-CACATGGGGATAGCACTAC-39), which is
complementary to a sequence present in the 39-end of all SARS-
CoV RNAs [5].
Determination of the polarity of in vitro synthesized
SARS-CoV RNA
In vitro transcribed RNAs (0.75 mg) corresponding to nt 29,364-
29,727 of the 39-terminal region (39-TR(+)) or complementary to
nt 1-378 (39-TR(2)) of the SARS-CoV genome were immobilized
to Hybond N+ membrane (GE Healthcare). As negative controls,
RNAs corresponding to nt 12,313–12,660 (ctrl. a) of the equine
arteritis virus genome or its complementary sequence (ctrl. b) were
included. The membrane with the immobilized probes was
prehybridized for 4 hours in a hybridization mixture containing
56SSPE (750 mM NaCl, 50 mM NaH2PO4, 5 mM EDTA,
pH 7.0), 0.05% SDS, 5x Denhardt and 100 mg/ml homomix I.
Subsequently, the membrane was hybridized with half of the
32P-
labeled RNA recovered from a 28-ml IVRA in 0.8 ml hybridiza-
tion mix, which was first heat denatured at 70uC for 15 min. After
hybridization for 16 h at 56uC, membranes were washed twice for
20 min at 56uC with 4 ml of 5x SSPE, 0.05% SDS, and the
hybridization signal was quantified by PhosphorImager analysis.
SDS-PAGE and Western blotting
Proteins were separated by SDS-PAGE and transferred to
Hybond-P PVDF membrane (GE Healthcare) by semi-dry
blotting. After blocking with 1% casein in PBS containing 0.1%
Tween-20 (PBST), membranes were incubated with anti-nsp3,
anti-nsp5 or anti-nsp8 rabbit antisera, diluted 1:2000 in PBST
with 0.5% casein and 0.1% BSA. Peroxidase-conjugated swine
anti-rabbit IgG antibody (DAKO) and the ECL-plus kit (GE
Healthcare) were used for detection.
Protease and nuclease protection assays
Protease protection experiments were done by incubating PNS
(50 ml) for 10 min at 20uC with 20 mg/ml of proteinase K either in
the absence or presence of 0.5% TX-100. After inactivation of the
protease by addition of 2 mM PMSF and fractionation into a
10,0006g pellet (P10) and supernatant (S10), samples were
analyzed by Western blotting. For nuclease protection assays, a
standard 100-min IVRA was performed with the PNS, after which
5U of Bal31 nuclease was added, either in the presence or in the
absence of 0.5% TX-100. After a 10-min incubation, samples
were fractionated into S10 and P10 fractions. Radiolabeled RNA
was isolated from the fractions and analyzed as described above.
Electron microscopy
One volume of 6% paraformaldehyde in 60 mM PIPES,
25 mM HEPES, 2 mM MgCl2, 10 mM EGTA, pH 6.9 was
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ml drops of these fixed P10 fractions and incubated at room
temperature for 1 min. After blocking with 1% BSA in PBS, grids
were incubated for 30 min with rabbit antisera directed against
nsp3, nsp4 or nsp6 (1:200) in PBS containing 1% BSA. Bound
rabbit IgG was detected with protein A carrying 15-nm gold
particles. After negative staining with 2% phosphotungstic acid,
grids were viewed in a FEI T12 transmission electron microscope
at 120 kV.
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